国家科技部4月23日在京召开新闻发布会宣布,我校邹全明教授率领他的团队历时15年研制的“口服重组幽门螺杆菌疫苗”(简称Hp疫苗),日前获国家食品药品监督管理局批准颁发的国家一类新药证书。这是迄今为止世界上首个Hp疫苗,标志着我国在预防幽门螺杆菌感染及相关胃病研究领域跃 Ministry of Science and Technology held a news conference in Beijing on April 23rd and announced that Professor Zou Quanming, our school, led his team to develop “oral recombinant Helicobacter pylori vaccine” (Hp vaccine) for 15 years and was recently approved by the State Food and Drug Administration Issued a class of new drug certificate. This is by far the world’s first Hp vaccine, marking a breakthrough in the prevention of Helicobacter pylori infection and related stomach diseases in China